
Sen. Tammy Baldwin @SenatorBaldwin
In 2018 alone, the 10 biggest drug companies spent $115 billion on their shareholders through stock buybacks and dividends instead of lowering prices. At the same time, big drug companies raised the price on thousands of drugs. — PolitiTweet.org